Industry News (Patents and Technology)

Patent Issued for Gene Implicated in Stem Cell Differentiation

Published in Gene Therapy Weekly, February 24th, 1997

ImClone Systems, Inc., New York, New York, announced that the U.S. Patent and Trademark Office has issued a patent covering the human and murine delta-like (DLK) gene.

DLK is a member of a family of proteins which appear to have the ability to maintain cells in an undifferentiated state. The patent, which is assigned to the U.S. National Institutes of Health (NIH), is exclusively licensed to ImClone for stem cell and gene therapy applications.

The DLK protein and gene were discovered by Dr. Jorge Laborda, U.S. Food and Drug Administration (FDA). In October 1996, ImClone signed an exclusive, worldwide patent license with the NIH for stem cell and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1997-02-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry